Back to Agenda
Session 5 / Venue 5: Current and Future: Medical Affairs and Medical Scientific Liaison (MSL)
Session Chair(s)
Kazuya Iwamoto, MD, PhD, FACP
Chairperson, The Japanese Association of Pharmaceutical Medicine (JAPhMed)
Senior Medical Director, Covance Inc., Japan
Recently, Medical Affairs and Medical Scientific Liaison (MSL) have been expanding rapidly in Japan, however, expected roles may vary among individual companies and the importance of these functions may be penetrated less sufficiently into both internal and external customers compared with western countries. In this session, we will present the outline of Medical Affairs and MSL and will try to figure out what are expected to Medical Affairs and MSL in Japan through discussions based on the results of surveys on Medical Affairs and MSL which PwC PRTM and we have conducted targeting for pharmaceutical companies in Japan.
Speaker(s)
Current and Future: Medical Affairs and Medical Scientific Liaison (MSL)
Kazuya Iwamoto, MD, PhD, FACP
Senior Medical Director, Covance Inc., Japan
Chairperson, The Japanese Association of Pharmaceutical Medicine (JAPhMed)
Current Status and Future Perspective of Medical Affairs Organization in Japan
Yoichi Inoue, JD, MD
GE Healthcare Japan, Japan
Medical Affair, Japan
Survey on the Functions and Challenges of Medical Scientific Liaison (MSL) in the Pharmaceutical industry
Hiroshi Aino, MD, PhD
Sumitomo Dainippon Pharma Co., Ltd., Japan
Senior Medical Officer
Have an account?